Skip to search boxSkip to navigationSkip to main content

Prevalence and antimicrobial resistance of non-ESKAPE-Ec Enterobacteriales in a IV-level hospital in Lima, Peru

  • Wilfredo Flores-Paredes
    ,
  • Nestor Luque
    ,
  • Roger Albornoz
    ,
  • Nayade Rojas
    ,
  • Manuel Espinoza
    ,
  • Joaquim Ruiz(corresponding author)
*Corresponding author for this work
  • Hospital Guillermo Almenara Irigoyen
    ,
  • Universidad Peruana Union
    ,
  • Ministerio de Salud, Lima
    ,
  • Instituto Nacional de Salud, Lima
    ,
Research Output:
Contribution to journal
Article
Peer-review

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 155-165 (11 pages)

Journal (Volume, Issue Number)

Acta Microbiologica Hellenica (Volume 66, Issue 2)

Publication milestones

  • Published - 01/04/2021

Publication status

Published - 01/04/2021

ISSN

0438-9573

Publication IDs

  • Scopus: 85129665297

Abstract

The aim of this work was to evaluate the levels and the evolution of antimicrobial resistance of non-ESKAPE-Ec Enterobacteriales (NEEcE, non Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp. and Escherichia coli) from a IV-level Peruvian hospital. NEEcE accounting for >0.5% of total isolates in 2009-2010 (Period 1) and/or 2012-2014 (Period 2) were included in the study. Bacterial identification and antimicrobial resistance was performed by automated methods. Additionally, the presence of extended spectrum beta-lactamases (ESBLs) was investigated in Klebsiella oxytoca. According to our results, Citrobacter freundii, Klebsiella oxytoca, Morganella morganii, Proteus mirabilis, Providencia spp. and Serratia marcescens fulfilled inclusion criteria, accounting for 695/9918 isolates (7.0%); 238/3777 (6.30%) in Period 1 and 447/6141 (7.28%) in Period 2 (p=0.0038). P. mirabiliswas the most frequent with 192 isolates (1.94%), while only 54 Providencia spp. (0.54%) were recovered. Carbapenems were the most active antibacterial agents. In general, the microorganisms showed lower or moderate levels of resistance to amikacin and piperacillin/tazobactam, while resistance levels to the remaining antibacterial agents were >40%. Multidrug resistance (MDR) levels varied from 36.1% in S. marcescens to 73.9% in P. mirabilis. Temporal analysis showed that the levels of antibiotic resistance tended to decrease or not to vary. This finding led to a MDR decrease, except for P. mirabilis and Providencia spp. The presence of ESBL was associated with significantly higher levels of resistance to noncephalosporin antibiotics, except imipenem. In conclusion, present results demonstrate the relevance of NEEcE, highlighting the need to include these Enterobacteriales in routine followup and also warn about the worrisome panorama of antibiotic resistance in the area.

Funding Details

jR was supported by the Fondo Nacional de Desar-rollo Científico, Tecnológico y de Innovación Tecnológica (FONDECYT – Perú) within the “Proyecto de Mejo-ramiento y Ampliación de los Servicios del Sistema Na-cional de Ciencia, Tecnología e Innovación Tecnológica” [contract: 08-2019-FONDECYT -BM-INC-INV”].
FundersFunding numbers
Proyecto de Mejo-ramiento y Ampliación de los Servicios del Sistema Na-cional de Ciencia, Tecnología e Innovación Tecnológica
08-2019-FONDECYT
FONDECYT
-

Publication metrics

Metrics

Scopus
Citations

PlumX

Captures
4